LEMAITRE VASCULAR INC (LMAT) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — LMAT

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	26.63	26.85	25.49	27.18	25.34	21.00	22.27	26.60	18.05	19.49	16.68	16.91	20.79	15.56	17.37	21.54	23.53
Accounts Receivable	35.68	35.77	32.42	36.54	35.11	32.27	30.82	30.24	23.88	26.41	25.37	20.09	21.54	21.39	19.50	20.74	20.13
Total Current Assets	488.30	477.82	452.03	430.13	408.11	227.12	212.81	202.96	182.18	174.49	164.77	153.14	148.49	141.41	134.02	90.02	90.66
Property, Plant & Equipment	29.59	28.54	26.46	25.36	25.11	23.92	23.12	22.17	21.36	21.22	19.24	15.35	15.75	16.68	17.00	15.79	15.20
Goodwill	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94	65.94
Intangible Assets	30.54	31.67	31.71	33.15	34.40	37.30	38.77	40.24	43.20	44.00	45.51	48.06	49.60	51.19	54.23	55.78	57.34
Total Non-current Assets*	152.25	151.71	146.04	147.47	147.89	149.91	150.27	151.00	151.83	151.98	150.10	148.91	150.94	151.04	155.46	156.49	156.71
Total Assets	640.55	629.53	598.07	577.59	556.01	377.03	363.08	353.96	334.01	326.47	314.87	302.05	299.43	292.45	289.47	246.51	247.37
Accounts Payable	3.24	4.18	3.47	4.91	2.18	1.65	2.00	3.09	4.37	3.52	3.37	2.85	2.84	2.19	3.14	2.06	2.56
Total Current Liabilities	29.94	33.37	33.29	30.82	24.75	29.34	25.45	26.81	29.03	25.86	23.90	23.44	23.41	18.27	22.11	21.48	22.30
Total Non-current Liabilities*	190.27	189.54	185.86	184.09	183.69	16.61	18.10	18.64	16.35	16.79	16.80	17.36	17.99	16.40	18.31	39.19	47.54
Total Liabilities	220.21	222.90	219.15	214.91	208.43	45.95	43.55	45.45	45.38	42.64	40.70	40.80	41.39	34.67	40.42	60.67	69.84
Retained Earnings	206.02	194.68	173.67	160.84	151.58	137.51	129.96	121.73	110.08	105.70	100.71	94.90	92.19	91.42	84.36	80.25	74.22
Total Stockholder Equity	420.34	406.62	378.92	362.69	347.57	331.07	319.53	308.50	288.64	283.83	274.17	261.25	258.03	257.79	249.05	185.83	177.53

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	70.38	66.55	64.45	61.05	64.23	59.87	55.72	54.82	55.85	53.48	48.88	47.41	50.12	47.08	40.95	39.03	42.11	39.56	39.50	38.37
Cost of Revenue	19.62	18.16	18.26	15.09	19.26	18.45	17.13	17.64	17.38	16.81	15.62	16.60	18.03	16.19	14.90	13.96	14.30	13.60	13.55	13.50
Gross Profit	50.76	48.40	46.19	45.96	44.97	41.42	38.59	37.18	38.47	36.67	33.27	30.82	32.09	30.88	26.05	25.07	27.81	25.96	25.96	24.87
Research & Development	4.85	4.06	3.53	2.97	3.54	4.10	3.62	3.66	4.28	4.09	4.35	4.22	4.52	3.88	3.55	3.46	3.35	2.93	3.46	2.85
Selling, General & Admin	11.11	12.05	10.39	10.75	10.40	10.49	9.49	8.93	8.82	9.01	8.44	7.74	7.72	7.93	6.93	7.23	7.33	7.25	6.75	6.00
Total Operating Expenses	30.37	30.62	27.36	25.64	28.83	28.79	25.74	24.03	24.09	24.79	23.06	21.64	22.63	23.01	19.09	18.92	22.03	18.03	17.66	15.79
Operating Income	20.40	17.77	18.83	20.31	16.14	12.63	12.85	13.15	14.38	11.87	10.21	9.18	9.45	7.87	6.97	6.15	5.78	7.93	8.30	9.07
Interest Expense	1.30	1.30	1.30	1.30	1.30	1.29	0.21	--	--	--	--	--	--	--	0.00	0.00	0.00	0.00	0.53	0.62
Pretax Income	22.19	19.67	20.30	22.57	18.07	14.24	14.02	14.55	15.51	12.80	11.31	9.83	10.32	8.02	7.80	6.15	5.55	8.00	7.91	8.43
Tax Provision	5.14	3.99	4.72	5.21	4.29	3.23	2.84	3.41	3.68	2.91	2.85	2.32	2.22	1.98	2.17	0.69	2.03	1.96	1.73	1.93
Net Income	17.05	15.68	15.58	17.36	13.78	11.01	11.18	11.14	11.83	9.89	8.47	7.50	8.10	6.04	5.63	5.46	3.52	6.04	6.18	6.50
Basic EPS	0.75	0.69	0.68	0.77	0.61	0.49	0.49	0.50	0.53	0.44	0.39	0.34	0.36	0.27	0.25	0.25	0.16	0.28	0.28	0.30
Diluted EPS	0.74	0.68	0.69	0.75	0.60	0.48	0.48	0.49	0.52	0.44	0.38	0.33	0.36	0.27	0.25	0.25	0.16	0.27	0.27	0.30

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	15.97	15.09	23.16	28.76	20.29	9.04	15.18	14.25	9.63	5.07	10.75	11.82	11.90	2.28	4.08	7.34	9.25	4.71	5.06	14.08
Capital Expenditures	2.31	2.78	1.78	2.28	1.34	1.38	2.04	1.67	1.88	1.37	1.28	1.05	2.80	2.13	1.26	0.46	0.97	0.54	0.61	1.81
Free Cash Flow*	13.65	12.31	21.38	26.48	18.95	7.66	13.14	12.58	7.75	3.70	9.47	10.77	9.10	0.15	2.82	6.88	8.28	4.18	4.45	12.26
Investing Cash Flow	(11.08)	(13.12)	(16.82)	(27.45)	(16.35)	(4.32)	(173.89)	(12.86)	(11.00)	(2.36)	(2.26)	(9.85)	(9.64)	(2.96)	(0.40)	(8.46)	(0.97)	(0.54)	(7.25)	(51.37)
Financing Cash Flow	(5.05)	(3.22)	(3.59)	(2.95)	(2.76)	(5.24)	164.08	(3.15)	(2.87)	0.04	(2.69)	(3.12)	0.50	(1.82)	(2.12)	(2.15)	(2.58)	(2.38)	(1.16)	33.37

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Dividends Per Share	0.25	0.25	0.20	0.20	0.20	0.20	0.16	0.16	0.16	0.16	0.14	0.14	0.14	0.14	0.13	0.13	0.13	0.13	0.11	0.11